Gabay Avraham has filed 11 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 95889 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on March 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 95889 | $0.00 | 745,145.0000 | 42,774,504 | 14.77% | 0.22% |
| Jan. 22, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | M | Performance Stock Units | 19000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.04% |
| Jan. 22, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | M | Common Stock | 19000 | $0.00 | 649,256.0000 | 42,774,504 | 3.01% | 0.04% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Performance Stock Units | 19000 | $0.00 | 19,000.0000 | 42,774,504 | 9999.99% | 0.04% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 81216 | $0.00 | 515,256.0000 | 42,774,504 | 18.71% | 0.19% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 115000 | $0.00 | 630,256.0000 | 42,774,504 | 22.32% | 0.27% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 34000 | $0.00 | 392,040.0000 | 40,828,380 | 9.50% | 0.08% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 42000 | $0.00 | 434,040.0000 | 40,828,380 | 10.71% | 0.10% |
| Jan. 2, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 188000 | $0.00 | 358,040.0000 | 40,828,380 | 110.56% | 0.46% |
| Nov. 7, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 170,040.0000 | 40,896,845 | 21.42% | 0.07% |
| June 21, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Gabay Avraham | Chief Financial Officer | A | Common Stock | 140040 | $0.00 | 0.0000 | 41,564,007 | 0.00% | 0.34% |